Table 3 The demographics related to all analyzed conditions in Austria.
Austria | ||||||
|---|---|---|---|---|---|---|
2017 | 2018 | 2019 | 2020 | 2021 | ||
TBI | ||||||
Age (median, IQR) | 57.0 (41.0–73.0) | 52.0 (36.0–71.0) | 57.5 (35.0–71.5) | 60.0 (38.0–74.5) | 48.5 (34.25–61.0) | |
Sex (male) | 27 (64.3%) | 29 (69.0%) | 18 (69.2%) | 17 (63.0%) | 22 (64.7%) | |
TBI grade | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | 3.0 (1.0–3.0) | 2.0 (1.0–3.0) | 2.5 (2.0–3.0) | |
Initial GCS | 10.0 (6.5–13.25) | 9.0 (6.0–14.0) | 7.0 (5.75–14.25) | 12.0 (8.0–13.75) | 8.0 (3.0–13.25) | |
GOSE (median, IQR) | 4.0 (3.0–7.0) | 3.5 (3.0–6.75) | 4.0 (3.0–6.0) | 4.0 (3.0–7.0) | 4.0 (3.0–6.0) | |
cSDH | ||||||
Age | 74.0 (65.6–73.0) | 77.0 (65.5–83.5) | 76.0 (69.25–81.0) | 76.0 (66.25–81.75) | 76.5 (67.0–81.25) | |
Sex (male) | 47 (65.3%) | 37 (58.7%) | 43 (69.4%) | 27 (71.1%) | 52 (72.2%) | |
Initial GCS | 15.0 (15.0–15.0) | 15.0 (14.0–15.0) | 15.0 (15.0–15.0) | 15.0 (14.0–15.0) | 15.0 (14.0–15.0) | |
GOSE | 8.0 (6.0–8.0) | 7.0 (6.0–8.0) | 8.0 (6.0–8.0) | 7.0 (5.0–8.0) | 7.0 (6.0–8.0) | |
SAH and Other Vascular Lesions | ||||||
Age | 58.2 (53.5–66.63) | 59.5 (50.75–68.25) | 55.0 (51.0–61.0) | 61.48 (46.3–70.0) | 58.0 (46.0–68.0) | |
Sex (male) | 9 (33.3%) | 24 (46.2%) | 19 (44.2%) | 21 (46.7%) | 12 (27.9%) | |
Initial GCS | 15.0 (13.0–15.0) | 14.5 (10.75–15.0) | 14.5 (10.5–15.0) | 14.0 (12.0–15.0) | 12.5 (3.0–15.0) | |
Aneurysms N (%) | 24 (88.9%) | 45 (88.2%) | 36 (83.7%) | 32 (72.7%) | 35 (83.3%) | |
Hunt&Hess Classification | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | 2.0 (1.0–4.0) | 2.0 (1.0–4.0) | 2.0 (2.0–4.0) | |
Fisher Classification | 3.0 (2.0–4.0) | 2.5 (2.0–4.0) | 2.5 (1.0–4.0) | 4.0 (2.0–4.0) | 4.0 (1.0–4.0) | |
Last mRS | 3.0 (1.0–4.0) | 3.0 (1.0–4.0) | 1.0 (0.0–3.0) | 2.5 (1.0–5.0) | 2.0 (1.0–4.0) | |
Timing of Aneurysm Treatment | 2.0 (1.0–2.0) | 1.0 (1.0–2.0) | 1.0 (1.0–2.25) | 1.0 (0.0–2.0) | 1.0 (1.0–1.0) | |
GOSE | 5.0 (3.0–7.0) | 5.0 (3.0–7.25) | 7.0 (2.75–8.0) | 5.5 (3.0–7.0) | 1.0 (0.0–5.0) | |
Spine Lesions | ||||||
Age | 59.0 (48.25–69.0) | 54.5 (43.25–64.0) | 60.0 (46.0–70.0) | 53.0 (41.0–69.0) | 60.0 (47.0–72.25) | |
Sex (male) | 54 (51.9%) | 64 (58.2%) | 63 (56.8%) | 40 (56.3%) | 73 (60.8%) | |
Timing from Symptoms to Surgery | 3.0 (3.0–4.0) | 4.0 (3.0–5.0) | 4.0 (2.5–5.0) | 3.0 (3.0–4.5) | 4.0 (3.0–5.0) | |
GOSE | 7.0 (6.0–8.0) | 7.5 (7.0–8.0) | 7.0 (6.0–7.0) | 7.0 (6.0–8.0) | 7.0 (6.0–7.0) | |
Acute Hydrocephalus | ||||||
Age | 54.0 (24.0–68.5) | 54.5 (35.0–76.75) | 53.0 (10.25–69.0) | 42.0 (13.0–56.0) | 59.0 (49.5–67.25) | |
Sex (male) | 36 (61.0%) | 24 (57.1%) | 28 (48.3%) | 13 (48.1%) | 34 (47.2%) | |
New Onset of Acute Hydrocephalus | 32 (54.2%) | 22 (52.4%) | 28 (48.3%) | 48 (66.7) | ||
GOSE | 7.0 (4.0–8.0) | 7.0 (4.0–8.0) | 6.0 (3.0–8.0) | 6.5 (4.0–8.0) | 4.0 (3.0–6.75) | |
Tumors and Other Intracranial Lesions | ||||||
Age | 62.0 (48.0–71.0) | 64.0 (53.0–73.0) | 59.0 (48.0–70.25) | 62.0 (54.0–70.0) | 62.0 (51.0–72.0) | |
Sex (male) | 55 (53.4%) | 68 (54.0%) | 58 (55.8%) | 76 (51.0%) | 59 (45.7%) | |
Seizures | 9 (8.7%) | 20 (16.0%) | 23 (22.1%) | 21 (14.3%) | 25 (19.4%) | |
Any Focal Neurological Deficit | 73 (70.9%) | 86 (68.3%) | 70 (67.3%) | 100 (68.5%) | 90 (69.8%) | |
GOSE | 6.0 (4.0–8.0) | 6.0 (4.0–7.0) | 6.0 (3.0–7.0) | 6.0 (4.0–7.0) | 6.0 (4.0–7.25) | |
